We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026
20 Aug 2026 - 22 Aug 2026

European Neurologic-Monitoring Market

By HospiMedica staff writers
Posted on 25 Oct 2006
The increasing prevalence of neurologic problems, concomitant with technology advances, are supporting high-growth potential in the European neurologic-monitoring market.

The rising incidence of epilepsy in developed nations and heightened awareness about sleep disorders, coupled with the rapid rise of sleep labs and sleep clinics, has greatly motivated and influenced the growth of the neurologic-monitoring market in such disorders. More...
However, the presence of well established participants and market saturation, together with a stagnant competitive landscape, is posing a serious challenge for newer companies to enter the market.

"Neurological monitoring is a technologically advanced market and is poised to revolutionize the monitoring of neurological parameters,” said C.R. Hema Varishika, a research analyst with Frost & Sullivan (Palo Alto, CA, USA), an international consulting company. "Market participants have shifted their focus towards new applications, like long-term monitoring of conditions such as epilepsy and sleep disorders that will drive market growth.”

"In this market with rising health expenditures and an unstable economy, tactical and well calculated measures have to be taken to develop and promote one's products,” cautioned Ms. Varshika. "Product development initiatives need to be based on research in emerging areas and be supported by strategic marketing. Proactive alliances and tactical marketing plans followed by effective execution will enable expansion in market share.”

According to Frost & Sullivan, the European neurologic-monitoring market earned revenues of $135.2 million in 2005 and is anticipated to reach $175.3 million in 2012.



Related Links:
Frost & Sullivan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Vessel Sealing Instrument
ERGOseal
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.